Greek pharmaceutical manufacturer scaling operations with enterprise ERP modernization
UNI-PHARMA operates a 200-500-person pharmaceutical manufacturing operation headquartered in Greece, with active R&D and commercial teams. The company is mid-implementation of SAP S/4HANA and carrying a hiring velocity skewed toward engineering and manufacturing roles — a pattern consistent with modernizing production infrastructure and automation. Pain points cluster around equipment reliability, multi-site network operations, and regulatory compliance, suggesting the organization is solving for operational scale rather than early-stage product discovery.
UNI-PHARMA manufactures pharmaceutical products for disease prevention and treatment, operating from Kifisiá in the Athens region. The company serves medical and commercial customers across Greece and maintains partnerships with pharmaceutical and academic institutions to expand into new therapeutic areas. Operations span multiple manufacturing sites, requiring coordinated network infrastructure and equipment maintenance. The organization is actively expanding its engineering and manufacturing teams while undertaking a significant enterprise-systems upgrade.
Windows Server, Microsoft 365, SAP, Cisco networking, VMware ESXi for virtualization, and PHP/JavaScript for internal web applications. The company is currently implementing SAP S/4HANA to modernize its ERP layer.
The company is focused on automation equipment performance, multi-site network operations, regulatory compliance, and SAP S/4HANA implementation. Warehouse automation maintenance and cost efficiency are active areas of improvement.
Other companies in the same industry, closest in size